Synlett 2007(10): 1577-1580  
DOI: 10.1055/s-2007-982556
LETTER
© Georg Thieme Verlag Stuttgart · New York

A Stereoselective Synthesis of the C20-C32 Fragment of the Phorboxazoles

J. S. Yadav*a, M. Satyanarayanaa, G. Srinivasulub, A. C. Kunwarb
a Division of Organic Chemistry, Indian Institute of Chemical Technology, Hyderabad 500007, India
b Centre for Nuclear Magnetic Resonance, Indian Institute of Chemical Technology, Hyderabad 500007, India
Fax: +91(40)7160387; e-Mail: yadavpub@iict.res.in;
Further Information

Publication History

Received 6 October 2006
Publication Date:
06 June 2007 (online)

Abstract

The C20-C32 fragment of the phorboxazoles was ­realized in a stereoconvergent manner utilizing a desymmetrization approach. This successful strategy involves epimerization and ­modified Julia olefination as key steps.

    References and Notes

  • 1a Searle PA. Molinski TF. J. Am. Chem. Soc.  1995,  117:  8126 
  • 1b Searle PA. Molinski TF. Brzezinski LJ. Leahy JW. J. Am. Chem. Soc.  1996,  118:  9422 
  • 1c Molinski TF. Tetrahedron Lett.  1996,  37:  7879 
  • 2a Ye T. Pattenden G. Tetrahedron Lett.  1998,  39:  319 
  • 2b Pattenden G. Plowright AT. Tornos JA. Ye T. Tetrahedron Lett.  1998,  39:  6099 
  • 2c Paterson I. Arnott EA. Tetrahedron Lett.  1998,  39:  7185 
  • 2d Williams DR. Clark MP. Berliner MA. Tetrahedron Lett.  1999,  40:  2287 
  • 2e Williams DR. Clark MP. Tetrahedron Lett.  1999,  40:  2291 
  • 2f Wolbers P. Misske AM. Hoffmann HMR. Tetrahedron Lett.  1999,  40:  4527 
  • 2g Wolbers P. Hoffmann HMR. Synthesis  1999,  797 
  • 2h Wolbers P. Hoffmann HMR. Tetrahedron  1999,  55:  1905 
  • 2i Misske AM. Hoffmann HMR. Tetrahedron  1999,  55:  4315 
  • 2j Rychnovsky SD. Thomas CR. Org. Lett.  2000,  2:  1217 
  • 2k Donaldson WA. Greer PB. Tetrahedron Lett.  2000,  41:  3801 
  • 2l Huang H. Panek JS. Org. Lett.  2001,  3:  1693 
  • 2m González MA. Pattenden G. Angew. Chem. Int. Ed.  2003,  42:  1255 
  • 2n Paterson I. Luckhurst CA. Tetrahedron Lett.  2003,  44:  3749 
  • 2o Chakraborty TK. Reddy VR. Reddy TJ. Tetrahedron  2003,  59:  8613 
  • 3a Forsyth CJ. Ahmed F. Cink RD. Lee CS. J. Am. Chem. Soc.  1998,  120:  5597 
  • 3b Evans DA. Fitch DM. Smith TE. Cee VJ. J. Am. Chem. Soc.  2000,  122:  10033 
  • 3c Smith AB. Minbiole KP. Verhoest PR. Schelhaas M. J. Am. Chem. Soc.  2001,  123:  10942 
  • 3d González MA. Pattenden G. Angew. Chem. Int. Ed.  2003,  42:  1255 
  • 3e Williams DR. Kiryanov AA. Emde U. Clark MP. Berliner MA. Reeves JT. Angew Chem. Int. Ed.  2003,  42:  1258 
  • 3f Smith AB. Razler TM. Ciavarri JP. Hirose T. Ishikawa T. Org. Lett.  2005,  7:  4399 
  • 3g Li DR. Zhang DH. Sun CY. Zhang JW. Yang L. Chen J. Liu B. Su C. Zhou WS. Lin GQ. Chemistry  2006,  12:  1185 
  • 4a Forsyth CJ. Ying L. Chen J. La Clair JJ. J. Am. Chem. Soc.  2006,  128:  3858 
  • 4b Uckun FM. Forsyth CJ. Bioorg. Med. Chem. Lett.  2001,  11:  1181 
  • 4c Chen J. Ying L. Hansen TM. Engler MM. Lee CS. La Clain JJ. Forsyth CJ. Bioorg. Med. Chem. Lett.  2006,  16:  901 
  • 4d Smith AB. Razler TM. Pettit GR. Chapuis J.-C. Org. Lett.  2005,  7:  4403 
  • 5a Yadav JS. Rao CS. Chandrasekhar S. Ramarao AV. Tetrahedron Lett.  1995,  36:  7717 
  • 5b Yadav JS. Abraham S. Reddy MM. Sabitha G. Sankar AR. Kunwar AC. Tetrahedron Lett.  2001,  42:  4713 
  • 5c Yadav JS. Abraham S. Reddy MM. Sabitha G. Sankar AR. Kunwar AC. Tetrahedron Lett.  2002,  43:  3453 
  • 5d Yadav JS. Md. Ahmed M. Tetrahedron Lett.  2002,  43:  7147 
  • 5e Yadav JS. Reddy KB. Sabitha G. Tetrahedron Lett.  2004,  45:  6475 
  • 5f Yadav JS. Srinivas R. Sathaiah K. Tetrahedron Lett.  2006,  47:  1603 
  • 6 Snider BB. Song F. Org. Lett.  2001,  3:  1817 
  • 7a Bernsmann H. Gruner M. Fröhlich R. Metz P. Tetrahedron Lett.  2001,  42:  5377 
  • 7b Klotz P. Mann A. Tetrahedron Lett.  2003,  44:  1927 
  • 8 Bolitt V. Mioskowski C. Kollah RO. Manna S. Rajapaksa D. Falck JR. J. Am. Chem. Soc.  1991,  113:  6320 
  • 10 Potman RP. Janssen NJML. Scheeren JW. Nivard RJF. J. Org. Chem.  1984,  49:  3628 
  • 11 Lafontaine JA. Provencal DP. Gardelli C. Leahy JW. J. Org. Chem.  2003,  68:  4215 
  • 12 Entwistle DA. Jordon SI. Montgomery J. Pattenden G. Synthesis  1998,  603 
  • 13 Mitsunobu O. Synthesis  1981,  1 
  • 14a Baudin JB. Hareau G. Julia SA. Ruel O. Bull. Soc. Chim. Fr.  1993,  130:  336 
  • 14b Baudin JB. Hareau G. Julia SA. Lorne R. Ruel O. Bull. Soc. Chim. Fr.  1993,  130:  856 
  • Review on modified Julia olefination:
  • 14c Blakemore PR. J. Chem. Soc., Perkin Trans. 1  2002,  2563 
9

The six-membered ring is in the chair form 5C2 conformation. C1-H, C3-H and C5-H have axial orientations confirmed by NOE enhancement between C1-H/C5-H, C1-H/C3-H and C3-H/C5-H and also between C4-Me/C2-H (Figure [1] ). This arrangement is also strongly supported by the coupling constants J C1-H-C2-H = 10.57 Hz, J C3-H-C2-H = 10.57 Hz and J C3-H-C4-H = 4.53 Hz.

Figure 1

15

Spectral Data: Compound 1 [α]D +28.26 (c 0.01, CHCl3); 1H NMR (200 MHz, CDCl3): δ = 0.82 (d, J = 6.07 Hz, 3 H), 0.96 (d, J = 6.96 Hz, 3 H), 1.60-2.16 (m, 4 H) 1.87 (s, 3 H), 2.42 (s, 3 H), 3.24 (dd, J = 5.20, 10.41 Hz, 1 H), 3.44-3.76 (m, 3 H), 4.30-4.68 (m, 5 H), 6.10 (s, 1 H), 7.20-7.34 (m, 10 H), 7.38 (s, 1 H); 13C NMR (50 MHz, CDCl3): δ = 5.80, 13.23, 13.69, 18.72, 33.02, 33,38, 34.44, 67.03, 69.97, 72.95, 74.46, 76.28, 76.92, 77.56, 79.77, 83.99, 119.46, 127.44, 127.62, 128.26, 135.18, 137.24, 138.49, 138.67; LC-MS: m/z = 476 [M + H+].
Compound 10: [α]D +57.29 (c 1.85, CHCl3); 1H NMR (200 MHz, CDCl3): δ = 0.98 (d, J = 7.18 Hz, 3 H), 1.05 (d, J = 7.81 Hz, 3 H), 2.0-2.20 (m, 2 H), 2.25-2.36 (dd, J = 3.9, 15.6 Hz, 1 H), 2.57-2.70 (m, 1 H), 3.30 (s, 3 H), 3.68 (s, 3 H), 3.84 (m, 1 H), 4.25-4.34 (m, 1 H), 4.47-4.50 (m, 3 H), 7.22-7.30 (m, 5 H); 13C NMR (50 MHz, CDCl3): δ = 8.91, 12.89, 35.45, 36.60, 37.31, 51.53, 54.74, 67.34, 69.99, 75.36, 103.42, 127.03, 127.20, 128.14, 172.00; MS (FAB): m/z = 291 [M+- OMe].
Compound 13: colorless oil; [α]D +50.5 (c 1.00, CHCl3); IR (KBr): 3029, 2871, 1743 cm-1; 1H NMR (200 MHz, CDCl3): δ = 1.00 (d, J = 7.23 Hz, 3 H), 1.32 (d, J = 7.23 Hz, 3 H), 1.72-2.12 (m, 2 H), 2.24-2.40 (m, 1 H), 2.72-2.88 (m, 1 H), 3.52-3.72 (m, 2 H), 3.88 (t, J = 5.78 Hz, 1 H), 4.44-4.56 (m, 5 H), 7.24-7.36 (m, 10 H); 13C NMR (50 MHz, CDCl3): δ = 8.64, 12.57, 32.41, 35.56, 39.46, 66.24, 73.19, 73.56, 76.26, 127.44, 127.73, 128.40, 137.78, 138.15, 174.34; MS (FAB): m/z = 369 [M + H+].
Compound 14: colorless oil; [α]D +76.5 (c 1.00, CHCl3); 1H NMR (200 MHz, CDCl3): δ = 0.96 (d, J = 7.55, 3 H), 1.36 (d, J = 6.79 Hz, 3 H), 1.72-1.84 (m, 1 H), 1.96-2.08 (m 1 H), 2.24-2.32 (m, 1 H), 2.44-2.56 (m, 1 H), 3.48 (dd, J = 3.77, 9.82 Hz, 1 H), 3.54-3.60 (m, 2 H), 4.32-4.64 (m, 5 H), 7.24-7.32 (m, 10 H); 13C NMR (75 MHz, CDCl3): δ = 4.72, 14.61, 33.03, 38.31, 65.92, 70.56, 73.17, 76.15, 80.39, 127.61, 128.43, 137.59, 173.54; MS (FAB): m/z = 369 [M + H+].
Compound 16: colorless oil; [α]D +54.54 (c 0.01, CHCl3); IR (KBr): 2961, 2926, 2179 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.17 (s, 9 H), 0.96 (d, J = 6.79 Hz, 3 H), 1.04 (d, J = 6.79 Hz, 3 H), 1.56-1.68 (m, 1 H), 1.76-2.04 (m, 3 H), 3.09 (dd, J = 4.53, 10.57 Hz, 1 H), 3.46-3.60 (m, 2 H), 3.60-3.64 (d, J = 10.57 Hz, 1 H), 4.10 (q, J = 7.55, 14.35 Hz, 1 H), 4.30 (d, J = 11.33 Hz, 1 H), 4.49 (s, 2 H), 4.59 (d, J = 12.06 Hz, 1 H), 7.20-7.34 (m, 10 H); 13C NMR (50 MHz, CDCl3): δ = 5.99, 14.19, 33.33, 34.47, 37.23, 67.02, 69.96, 73.71, 75.98, 83.05, 103.65, 127.74, 128.44, 138.59; LC-MS: m/z = 450 [M + H+].
Compound 4: colorless oil; [α]D +90.0 (c 0.01, CHCl3); IR (KBr): 2969, 2926, 2858, 1718 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.84-0.98 (m, 6 H), 1.60-2.20 (m, 4 H), 2.11 (s, 3 H) 3.18 (dd, J = 4.68, 10.93 Hz, 1 H), 3.32 (d, J = 10.93 Hz, 1 H), 3.44-3.64 (m, 3 H), 4.32-4.70 (m, 4 H), 7.28 (m, 10 H); 13C NMR (75 MHz, CDCl3): δ = 6.98, 19.44, 26.51, 27.39, 28.40, 60.78, 64.133, 67.09, 69.16, 70.69, 71.11, 71.53, 77.26, 81.76, 121.69, 121.77, 122.44, 122.45, 132.39, 132.49, 201.15; LC-MS: m/z = 397 [M + H+].
Compound 5: IR (KBr): 3029, 2871, 1743 cm-1; 1H NMR (400 MHz, CDCl3): δ = 2.28 (s, 3 H), 4.71 (s, 2 H), 7.54-7.69 (m, 3 H), 7.99 (m, 1 H), 8.24 (m, 1 H); ESI-MS: m/z 295 [M + H+].